| 1 |
Michael R. Johnson |
Parion Sciences |
11 |
| 2 |
John W. A. Findlay |
Burroughs Wellcome |
3 |
| 3 |
Wolfgang Wagner |
U.S. Philips |
2 |
| #4 |
Gertrude B. Elion |
Burroughs Wellcome |
1 |
| #4 |
Charles R. Horres, Jr. |
Pharmetrix |
1 |
| #4 |
Joachim D. Geratz |
Research Triangle Institute |
1 |
| #4 |
Ralph Vinegar |
Burroughs Wellcome |
1 |
| #4 |
Iris H. Hall |
Boron Biologicals |
1 |
| #4 |
Barbara Roth |
Burroughs Wellcome |
1 |
| #4 |
Henry Fuchs |
University Of North Carolina At Chapel Hill |
1 |
| #4 |
Prabhavathi Fernandes |
Cempra Pharmaceuticals |
1 |
| #4 |
Lola Cynthia McAdams Reid |
University Of North Carolina At Chapel Hill |
1 |
| #4 |
Eugene M. Grivsky |
Burroughs Wellcome |
1 |
| #4 |
James L. Vorhaus |
Sarda Technologies |
1 |
| #4 |
John C. Opfer |
S&C Electric |
1 |
| #4 |
William C. Black |
AMD |
1 |
| #4 |
Norbert Hiller |
Cree |
1 |
| #4 |
Thomas A. Krenitsky |
Burroughs Wellcome |
1 |
| #4 |
Richard Holloway |
Deltasphere |
1 |
| #4 |
James Kolodzey |
University Of Delaware |
1 |
| #4 |
Eric C. Bigham |
Burroughs Wellcome |
1 |
| #4 |
Morton Harfenist |
Burroughs Wellcome |
1 |
| #4 |
Hugh H. Rowan |
Allied Consulting |
1 |
| #4 |
Joseph E. Lucas |
Duke University |
1 |
| #4 |
David W. Henry |
Sri International |
1 |